Meta-analysis of 15 observational studies links e-cigarette use to higher COPD odds
This meta-analysis synthesized data from 15 observational studies to evaluate the association between e-cigarette use and the prevalence of chronic obstructive pulmonary disease (COPD). The setting of these studies was not reported, and absolute numbers were not provided in the source data. The analysis categorized participants by current use, former use, exclusive use, dual use, and current use with a smoking history.
The results demonstrated significantly higher odds of having COPD among current e-cigarette users (OR = 2.03, 95% CI: 1.61–2.56) and former users (OR = 1.82, 95% CI: 1.38–2.41). Exclusive e-cigarette users showed an OR of 2.09 (95% CI: 1.46–3.00), while dual users exhibited the highest odds with an OR of 3.13 (95% CI: 2.01–4.87). Current users with a smoking history also displayed higher prevalence with an OR of 2.17 (95% CI: 1.41–3.35).
The authors acknowledge that confounding effects of traditional cigarette use remain a significant limitation, as the independent relationship with COPD is still unclear. Sensitivity analysis supported the robustness of these findings, and no evidence of publication bias was observed. Long-term health effects remain uncertain, and adverse events were not reported. Clinicians should interpret these pooled odds ratios cautiously given the observational nature of the included studies.